Joshua Zeichner, MD discusses three new treatments now available in the acne treatment armamentarium. For patients with severe acne, a new low-dose isotretinoin in a micronized formulation allows for better absorption, even without food. Dr. Zeichner also discusses the benefits of a new topical retinoid as well as a new topical minocycline.
More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age and older. The US affiliate of BTL Aesthetics has filed suit against Allergan and Germany’s Zimmer MedizinSysteme in the US Federal District Court for the District of Delaware, asserting that the Cooltone device infringes on BTL's US patents.
News | October 21, 2019
The FDA has approved Amzeeq (minocycline) topical foam, 4%, from Foamix Pharmaceuticals for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older....
Joshua Zeichner, MD discusses three new treatments now available in the acne treatment armamentarium. For patients with severe acne, a new low-dose...
Joshua Zeichner, MD
Ortho Dermatologics Launches Telemedicine on Dermatology.com, US Cash-Pay Prescription Program
Acne Pipeline Watch: Dermata Therapeutics Completes Enrollment in Phase 2b Trial of Once-Weekly Topical DMT310 for Acne
DermWireTV: Barbie Gets Inclusive, Hacking Prizes, Maui Derm Updates
Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposium